Post-approval Study of Transcarotid Artery Revascularization in Standard Risk Patients With Significant Carotid Artery Disease
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jeffrey Jim, MD
Abbott Northwestern Minneapolis Heart Institute Foundation
Principal Investigator - Marc Schermerhorn, MD
Beth Israel Deaconess Medical Center
Principal Investigator - Meghan Dermody, MD
Lancaster General Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
53 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Valley Vascular Consultants
Huntsville, Alabama, United States
- Honorhealth
Scottsdale, Arizona, United States
- Pima Heart & Vascular
Tucson, Arizona, United States
- University of California, San Diego (ucsd)
La Jolla, California, United States
- Sharp Grossmont
La Mesa, California, United States
- University of California, Los Angeles (ucla)
Los Angeles, California, United States
- Yale University
New Haven, Connecticut, United States
- Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
- Morton Plant Hospital
Clearwater, Florida, United States
- Delray Medical Center
Delray Beach, Florida, United States
- Mount Sinai Medical Center
Miami Beach, Florida, United States
- Adventhealth Ocala
Ocala, Florida, United States
- Coastal Vascular & Interventional
Pensacola, Florida, United States
- Northside Vascular
Cumming, Georgia, United States
- Alexian Brothers Medical Center
Elk Grove Village, Illinois, United States
- Carle Health
Urbana, Illinois, United States
- Deaconess Research / Evansville Surgical Associates
Evansville, Indiana, United States
- Indiana University
Indianapolis, Indiana, United States
- Baton Rouge General
Baton Rouge, Louisiana, United States
- Acadiana Vascular Clinic / Our Lady Lourdes Heart Hospital
Lafayette, Louisiana, United States
- Maine Medical Center
Portland, Maine, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Mclaren Heart & Vascular
Bay City, Michigan, United States
- Corewell Health
Grand Rapids, Michigan, United States
- Abbott Northwestern
Minneapolis, Minnesota, United States
- St. Luke'S Hospital
Chesterfield, Missouri, United States
- Midwest Aortic & Vascular Institute
North Kansas City, Missouri, United States
- Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Long Island Jewish Medical Center
New Hyde Park, New York, United States
- New York University
New York, New York, United States
- the Mount Sinai Hospital
New York, New York, United States
- University of Rochester
Rochester, New York, United States
- Atrium Health
Charlotte, North Carolina, United States
- Duke University
Raleigh, North Carolina, United States
- Bethesda North Hospital
Cincinnati, Ohio, United States
- St. Charles Health System
Bend, Oregon, United States
- Providence St. Vincent
Portland, Oregon, United States
- St. Luke'S University Hospital
Bethlehem, Pennsylvania, United States
- Upmc Pinnacle
Harrisburg, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Sept 2022
- Primary completion
- 22 Jul 2025
- Completion
- 22 Jul 2025
- Last update posted
- 30 Jul 2025
- Registered enrollment
- 344
- Registry id
- NCT05365490
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.